Atopic dermatitis: Recommendations for dietary interventions

  • Food elimination diets based solely on the findings of food allergy test results are not recommended for the management of AD.

Level of Evidence: II   Strength of Recommendation: B

  • If a patient has a true immunoglobulin E-mediated allergy, he or she should practice avoidance to prevent potential serious health sequelae.

Level of Evidence: I   Strength of Recommendation: A

  • Children less than 5 years of age with moderate to severe AD should be considered for food allergy evaluation for milk, egg, peanut, wheat, and soy if at least 1 of the following is met: (A) persistent AD in spite of optimized treatment or (B) having a reliable history of immediate reaction after ingestion of a specific food.

Level of Evidence: I   Strength of Recommendation: A

  • The use of probiotics/prebiotics for the treatment of patients with established AD is not recommended because of inconsistent evidence.

Level of Evidence: II   Strength of Recommendation: B

  • There is inconsistent to no evidence to recommend the use of fish oils, evening primrose oil, borage oil, multivitamin supplements, zinc, vitamin D, vitamin E, and vitamins B12 and B6 for the treatment of AD. 

Level of Evidence: II   Strength of Recommendation: B


Navigate section 4 of the AD guideline: Disease flares and adjunctive therapy

Citation note

When referencing this guideline in a publication, please use the following citation: Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec;71(6):1218-33.

 


View the AAD guidelines disclaimer.